Posted by John Deo
Barclays maintains an "Overweight" rating for Jazz Pharmaceuticals (NASDAQ:JAZZ), increasing the price target
Source: Two Blokes Trading
Posted by John Deo
Barclays has set a new price target for Nutanix (NASDAQ:NTNX) at $94, indicating a potential upside of 38.13%
Source: Two Blokes Trading
Posted by John Deo
Barclays maintains an "Overweight" rating for Nutanix, Inc. (NASDAQ:NTNX), indicating a positive outlook. The
Source: Two Blokes Trading
Posted by John Deo
Analyst Price Target: Betty Jiang from Barclays sets a price target of $43 for NYSE:RRC, indicating an 11.54%
Source: Two Blokes Trading
Posted by John Deo
Sphere Entertainment Co. (NYSE:SPHR) is a key player in the entertainment sector, gearing up for its upcoming
Source: Two Blokes Trading
Posted by John Deo
Revolve Group (NYSE:RVLV) delivered impressive fourth-quarter results, exceeding analyst expectations as reven
Source: Two Blokes Trading
Posted by John Deo
Lowe’s (NYSE:LOW) delivered an unexpected rise in fourth-quarter comparable sales, as its dual focus on retail
Source: Two Blokes Trading
Posted by John Deo
First Solar (NASDAQ:FSLR) fell short of Wall Street earnings expectations for the fourth quarter, but its reve
Source: Two Blokes Trading
Posted by John Deo
Workday (NASDAQ:WDAY) saw its stock surge over 7% intra-day today after delivering better-than-expected fourth
Source: Two Blokes Trading
Posted by John Deo
Advance Auto Parts (NYSE:AAP) delivered stronger-than-expected fourth-quarter results, but its shares dropped
Source: Two Blokes Trading
Posted by John Deo
Anheuser-Busch InBev (NYSE:BUD) delivered a robust fourth-quarter performance, exceeding analyst expectations
Source: Two Blokes Trading
Posted by John Deo
Energy Transfer has seen its units rise by over 40% since the start of 2023, with a high-yielding distributio
Source: Two Blokes Trading